PLoS ONE · 2013 · 129 citations · 41 references
Public HealthInfectious DiseasesPreventive MedicineCost-effectiveness AnalysisEarly DetectionInfection PreventionAntiretroviral TherapyHiv DiagnosisHiv TestingInfection ManagementInfectious Disease ScreeningOpportunistic Infection PreventionCost-effectivenessCryptococcal Antigen ScreeningCryptococcal Disease ScreeningCryptococcal Infection TreatmentCryptococcal MeningitisFluconazole TherapyProgrammatic ImplementationRoutine Screening
OBJECTIVES: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in South Africa we performed a cost-effectiveness analysis of alternative preventive strategies for CM. DESIGN: Cost-effectiveness analysis. METHODS: Using South African data we modelled the cost-effectiveness of four strategies for patients with CD4 cell-counts <100 cells/µl starting ART 1) no screening or prophylaxis (standard of care), 2) universal primary fluconazole prophylaxis, 3) CRAG screening with fluconazole treatment if antigen-positive, 4) CRAG screening with lumbar puncture if antigen-positive and either amphotericin-B for those with CNS disease or fluconazole for those without. Analysis was limited to the first year of ART. RESULTS: The least costly strategy was CRAG screening followed by high-dose fluconazole treatment of all CRAG-positive individuals. This strategy dominated the standard of care at CRAG prevalence ≥0.6%. Although CRAG screening followed by lumbar puncture in all antigen-positive individuals was the most effective strategy clinically, the incremental benefit of LPs and amphotericin therapy for those with CNS disease was small and additional costs were large (US$158 versus US$51 per person year; incremental cost effectiveness ratio(ICER) US$889,267 per life year gained). Both CRAG screening strategies are less costly and more clinically effective than current practice. Primary prophylaxis is more effective than current practice, but relatively cost-ineffective (ICER US$20,495). CONCLUSIONS: CRAG screening would be a cost-effective strategy to prevent CM-related mortality among patients initiating ART in South Africa. These findings provide further justification for programmatic implementation of CRAG screening.
41
Markov Models in Medical Decision Making
Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations
Sara A. Mirza, Maureen Phelan, David Rimland et al. · Clinical Infectious Diseases · 2003 · 459 citations
Veterinary Medicine, Infectious Diseases, Disease Surveillance +16
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
Neil French, Katherine J. Gray, Christine Watera et al. · AIDS · 2002 · 424 citations